Minimizing Waste and Lowering Cost by Addressing Duplicative Therapy for Diabetes
Background:
GLP-1s have revolutionized diabetes therapy in recent years. These important therapies are having significant impact on members, but payer affordability can be a challenge. We are finding that member-level regimens may contain older oral diabetic medications that do not add clinical value to a GLP-1 drug and contribute to waste.
Opportunity:
Our pharmacy team identified a member taking a GLP-1 and an older oral diabetic medication together.
Result:
We contacted the provider’s office to discuss the regimen and lack of evidence available to demonstrate effectiveness and the prescriber opted to discontinue the older medication.
Savings:
Annual Client Savings: $6,000+ (per conversion)
Annual Member Savings: $300
Want to see how you could save? Contact us for an ROI guarantee proposal to see.
Results may vary based on formulary design. Past results do not guarantee future results.